Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of systemic sclerosis].

M Meurer1, P Rehberger

  • 1Dermatologie am Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. Michael.Meurer@uniklinikum-dresden.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|September 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteasome-dependent protein quality control of the peroxisomal membrane protein Pxa1p.

Biochimica et biophysica acta. Biomembranes·2020
Same author

[37-year-old male with confluent papules and arcuate erythematosquamous plaques on the upper trunk and arms : Preparation for the specialist examination: part 22].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[In memory of Prof. Dr. med. Dr. h.c. mult. Otto Braun-Falco].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2018
Same author

[Systemic treatment of vitiligo : Balance and current developments].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017
Same author

[Pigmentation disorders].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017
Same author

[Oculocutaneous and ocular albinism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Systemic sclerosis therapy is challenging, particularly for organ involvement like kidneys and lungs. This article reviews organ-specific treatments, disease-modifying drugs, and hematopoietic stem cell transplantation (HSCT) for systemic sclerosis (SSc).

Area of Science:

  • Rheumatology
  • Dermatology
  • Internal Medicine

Context:

  • Systemic sclerosis (SSc) presents significant therapeutic challenges across multiple medical disciplines.
  • Organ involvement, especially in the kidneys and lungs, is a critical concern in SSc management.

Purpose:

  • To review current developments in organ-specific therapies for systemic sclerosis.
  • To discuss the potential of disease-modifying drugs and hematopoietic stem cell transplantation (HSCT) in SSc treatment.

Summary:

  • The article focuses on advancements in managing kidney and lung involvement in systemic sclerosis.
  • It explores emerging therapeutic strategies and evaluates the role of disease-modifying agents and HSCT.

Impact:

Related Experiment Videos

  • Provides an overview of the latest therapeutic approaches for systemic sclerosis.
  • Aids clinicians in managing complex organ involvement and considering novel treatment options like HSCT.